483
Biomat USA, Inc.Biomat USA, Inc. – FDA 483, Feb 13, 2025
Record Details
An FDA inspection of Biomat USA, Inc. in Allentown, PA, conducted from February 10-13, 2025, identified a significant issue regarding phlebotomy site preparation. Specifically, a phlebotomist was observed palpating a venipuncture site without proper re-scrubbing, which could compromise the sterility of collected blood. This observation indicates a potential risk to donor safety and product quality.
View Company Profile
ID · bb801b30-1b9a-4a23-a3ff-d2e1fa01382b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.